Edition:
United States

Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

23.35USD
19 Sep 2017
Change (% chg)

$0.30 (+1.30%)
Prev Close
$23.05
Open
$23.20
Day's High
$23.40
Day's Low
$22.85
Volume
420,553
Avg. Vol
869,414
52-wk High
$33.00
52-wk Low
$13.60

All Insider Trades
Trading Date Name Title Type Shares Traded Price
28 Aug 2017

Scopia Capital Management, L.P.

Beneficial Owner of More than 10% Class Buy 116,201 $19.62
28 Aug 2017

Scopia Capital Management, L.P.

Beneficial Owner of More than 10% Class Buy 500,000 $19.05
28 Aug 2017

Scopia Capital Management, L.P.

Beneficial Owner of More than 10% Class Buy 150,000 $19.52
31 Jul 2017

Greene (Barry E)

Director Sell 10,000 $21.57
31 Jul 2017

Rauscher (Steven M)

Director Buy 10,000 $18.21
31 Jul 2017

Rauscher (Steven M)

Director Sell 10,000 $21.57
31 Jul 2017

Greene (Barry E)

Director Buy 10,000 $18.21
30 Jul 2017

Randall (Lorin J)

Director Buy 10,000 $18.21
30 Jul 2017

Randall (Lorin J)

Director Sell 10,000 $21.66
15 Jun 2017

Cohen (Ron)

Chief Executive Officer Buy 20,000 $16.95
14 May 2017

Hindman (Andrew Asa)

Officer Sell 7,704 $15.75
28 Feb 2017

Cohen (Ron)

Chief Executive Officer Buy 11,960 $0.00
28 Feb 2017

Hindman (Andrew Asa)

Officer Buy 4,600 $0.00
28 Feb 2017

Blight (Andrew R)

Officer Buy 2,036 $0.00
28 Feb 2017

Lawrence (David W)

Officer Buy 4,400 $0.00
28 Feb 2017

Blank (Burkhard)

Officer Buy 4,200 $0.00
28 Feb 2017

Batycky (Richard P. Ph.D.)

Chief Technology Officer Buy 4,400 $0.00
28 Feb 2017

Sabella (Lauren M)

Officer Buy 4,400 $0.00
28 Feb 2017

Wasman (Jane)

General Counsel Buy 5,000 $0.00
8 Feb 2017

Greene (Barry E)

Director Sell 723 $22.65
8 Feb 2017

Greene (Barry E)

Director Buy 723 $22.13
8 Feb 2017

Blight (Andrew R)

Officer Buy 67,586 $22.13
8 Feb 2017

Wasman (Jane)

General Counsel Sell 54,536 $22.30
8 Feb 2017

Lawrence (David W)

Officer Sell 63,183 $22.32
8 Feb 2017

Wasman (Jane)

General Counsel Buy 54,536 $22.13

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 241
Total Shares Held: 52,342,075
3 Mo. Net Change: 2,265,666
# New Positions: 21
# Closed Positions: 51
# Increased Positions: 106
# Reduced Positions: 110
# Net Buyers: -4

Officers & Directors

Name Age Since Current Position

Ron Cohen

61 President,Chief Executive Officer, Director

Richard Batycky

49 2014 Chief Technology Officer and Site Head

David Lawrence

59 2016 Chief Business Operations, Principal Accounting Officer

Andrew Blight

66 2004 Chief Scientific Officer

Jane Wasman

61 2012 President - International, General Counsel, Corporate Secretary

Burkhard Blank

62 2016 Chief Medical Officer

Andrew Hindman

44 2014 Chief Business Development Officer

Lauren Sabella

56 2015 Chief Commercial Officer

Barry Greene

53 2007 Independent Director

Peder Jensen

62 2011 Independent Director

John Kelley

63 2008 Independent Director

Sandra Panem

70 1998 Independent Director

Lorin Randall

70 2006 Independent Director

Steven Rauscher

63 2005 Independent Director

Ian Smith

51 2007 Independent Director

Catherine Strader

51 2017 Independent Director